Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial comparing salvage radiotherapy with individualized PSMA PET/CT–targeted treatment for relapsing prostate cancer, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stefan Carlsson | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING